UK Biobank Copy Number Variant Study of 470,000 People Corrects Omission from Consortium List
Correction to the member list, not the research data
A Nature author correction published on March 31, 2026, addresses an omission from the consortium member list for a copy number variant study involving the genomes of 470,727 UK Biobank participants. The correction adds Dimitrios Vitsios to the AstraZeneca Genomics Initiative list. The notice reports no changes to tables, numerical results, or analysis data.
The original study is titled “Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomes” and was published online on February 4, 2026. The study size stated in its title is approximately 470,000 people. This correction should be read as an update to the record of consortium participation in the study.
Missing name added to HTML and PDF versions
According to the notice, Dimitrios Vitsios was omitted from the AstraZeneca Genomics Initiative member list in the original publication. His affiliation is listed as the Centre for Genomics Research in AstraZeneca’s BioPharmaceuticals R&D division in Cambridge, UK.
The omitted name has been added to the HTML and PDF versions of the paper. The correction concerns the consortium member list, and the notice explicitly states that the name was omitted and has been added. It does not explain how the omission occurred or describe the member’s specific research contributions.
Scope of the correction and interpretation of the findings
This notice alone provides no basis for concluding that associations between copy number variants and disease have changed or that the data need to be reanalysed. Changes in research direction or therapeutic target selection likewise cannot be inferred from this correction.
The correction notice does not provide the original study’s detailed analytical methods, disease-specific results, or effect sizes. Assessing the study’s scientific contributions and limitations requires consulting the paper’s methods and results separately. The change confirmed by this notice is an update to the consortium member list. Details are available in the Nature author correction notice.
Nature, Published online: 31 March 2026; doi:10.1038/s41586-026-10389-8 Author Correction: Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomes
This correction helps ensure an accurate record of research participation. Researchers examining the paper’s consortium membership or compiling information about contributors can consult the HTML and PDF lists containing the added name. When preparing literature reviews or research summaries, they should take care not to describe this notice as a correction of errors in tables, numerical results, or analysis data. The change specified in the notice is the addition of an omitted member; it reports no change to the research findings or their clinical interpretation. Evidence for assessing disease associations involving copy number variants or their value as therapeutic targets must be sought in the original study’s methods and results, rather than in this correction notice.